A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
BeOne Medicines
BeOne Medicines
Incyte Corporation
AbbVie
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Janssen Research & Development, LLC
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Vividion Therapeutics, Inc.
Seagen Inc.
Novartis
Hoffmann-La Roche
CytomX Therapeutics
EMD Serono
Pfizer
Whitehawk Therapeutics, Inc.
Pfizer
AstraZeneca
Genentech, Inc.
Regeneron Pharmaceuticals
AbbVie
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Incyte Corporation
Myeloid Therapeutics
EMD Serono
GlaxoSmithKline
Tesaro, Inc.
AbbVie
Amgen
Sutro Biopharma, Inc.
Toray Industries, Inc
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Sapience Therapeutics
Exelixis
Inspirna, Inc.
IGM Biosciences, Inc.
Onward Therapeutics
Boehringer Ingelheim
Hansoh BioMedical R&D Company
Qilu Pharmaceutical Co., Ltd.
Genentech, Inc.
MEI Pharma, Inc.
Pfizer
Taiho Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co. Ltd
Taiho Oncology, Inc.
Chugai Pharmaceutical
Ono Pharmaceutical Co. Ltd
Servier